Targeted O2 delivery by blood substitutes: in vitro arteriolar simulations of first- and second-generation products
Targeted O2 delivery by blood substitutes: in vitro arteriolar simulations of first- and second-generation products
复制标题
DOI:
10.1016/j.mvr.2008.07.002
复制
发表时间:
2008-11-01
影响因子:
3.1
通讯作者:
Winslow, Robert
中科院分区:
文献类型:
--
作者:
Cole, Russell;Vandegriff, Kim;Winslow, Robert
The O-2 transport from mixtures of commercially produced hemoglobin-based O-2 carriers (HBOCs) and red blood cells (RBCs) flowing through arteriolar-sized (25-mu m) conduits is simulated. A generalized treatment of extraluminal O-2 transport processes is used to reflect variations in physiological conditions, such as increased O-2 consumption. Of the HBOCs considered, polymerized bovine hemoglobin (PolyBvHb, p50 = 54mmHg), tetrameric cross-linked human hemoglobin (alpha alpha Hb, p50 = 33mmHg), and PEGylated human hemoglobin (MP4, p50 = 5mmHg), only MP4 does not increase O-2 extraction ratios when compared to RBC suspensions alone. A reduction in arteriolar O-2 extraction is likely to be beneficial for HBOCs by preventing O-2-induced vasoactivity and maximizing the Supply of O-2 available to the capillaries. Results from in vivo HBOC transfusion experiments cannot be predicted by the model, unless PolyBvHb has a significant decrease in extraluminal O-2 transport resistance as compared to MP4. This result is consistent with the literature that shows arteriolar O-2 consumption to increase with intravascular pO(2). (C) 2008 Elsevier Inc. All rights reserved